58 results
Page 2 of 3
8-K
EX-99.1
nowtg7 4u
12 May 22
Yumanity Therapeutics Reports First Quarter 2022 Financial Results and Recent Corporate Developments
4:52pm
8-K
EX-99.1
g7rmwr
24 Mar 22
Yumanity Therapeutics Reports Full-Year 2021 Financial Results and Recent Corporate Developments
4:21pm
8-K
EX-10.1
61koum 13py
4 Mar 22
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-99.1
mp1 d5ipfzg
17 Feb 22
Yumanity Therapeutics Exploring Strategic Alternatives to Enhance Shareholder Value and Announces Restructuring
8:37am
8-K
EX-99.1
s23jlgrd
10 Nov 21
Regulation FD Disclosure
7:12am
8-K
EX-99.1
rmbcc9a5
17 May 21
Regulation FD Disclosure
5:03pm
8-K
EX-99.1
bx4yrpxyjps 6r
10 Feb 21
Yumanity Therapeutics Provides Update on Its Lead Parkinson’s Disease Clinical Program, YTX-7739
8:13am
8-K/A
EX-99.7
a5xpc ydo
3 Feb 21
Other Events
4:59pm
8-K/A
EX-99.3
b6txmz1i
3 Feb 21
Other Events
4:59pm
8-K/A
EX-99.1
i2jcie 00
3 Feb 21
Other Events
4:59pm
8-K/A
EX-99.2
wdqnchvub
3 Feb 21
Other Events
4:59pm
8-K/A
EX-99.4
fmxfsk kgveyr6py
3 Feb 21
Other Events
4:59pm